In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 2.76 below Pulmonx Corporation average.

Within Medical Equipment & Supplies industry 62 other companies have achieved higher Quick Ratio than Pulmonx in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 849 to 1040.

Explain Quick Ratio?
How much Cash & cash equivalents LUNG�s has?
What are LUNG�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LUNG Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	-9.1 %	-24.21 %	-17.92 %	25.02 %	37.7 %
Y / Y Cash & cash equivalent Change	-25.27 %	-17.41 %	-1.63 %	20.91 %	18.91 %
Quick Ratio MRQ	2.76	3.26	3.48	3.35	3.36
LUNG's Total Ranking	# 1040	# 849	# 776	# 746	# 637
Seq. Current Liabilities Change	7.93 %	-5.74 %	-12.33 %	1.92 %	-10.01 %
Seq. Cash & cash equivalent Change	-8.41 %	-11.73 %	-8.88 %	1.44 %	1.22 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 63
Healthcare Sector	# 417
Overall Market	# 1040

Quick Ratio Statistics
High	Average	Low
18.49	6.42	2.44
(Dec 31 2020)		(Dec 31 2019)

Financial Statements
Pulmonx's Current Liabilities	$ 20 Millions	Visit LUNG's Balance sheet
Pulmonx's Cash & cash equivalent	$ 56 Millions	Visit LUNG's Balance sheet
Source of LUNG's Sales		Visit LUNG's Sales by Geography

Cumulative Pulmonx's Quick Ratio

LUNG's Quick Ratio for the trailling 12 Months

LUNG Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-8.75 %	0.36 %	12.44 %	8.09 %	0.36 %
Y / Y Cash & cash equivalent TTM Growth	-7.03 %	4.08 %	10.63 %	6.06 %	-8.93 %
Quick Ratio TTM	3.21	3.36	3.28	3.14	3.15
Total Ranking TTM	# 3793	# 3761	# 2850	# 3150	# 2672
Seq. Current Liabilities TTM Growth	-2.42 %	-6.69 %	-4.62 %	5.08 %	7.32 %
Seq. Cash & cash equivalent TTM Growth	-6.73 %	-4.38 %	-0.39 %	4.66 %	4.41 %

Quick ratio ranking by company, industry and sector >> Back to LUNG Financial Strength Comparisons >> Go to Compare LUNG Quick Ratio to its Competitors

News about Pulmonx Corporation Quick Ratio

Pulmonx Corporation Grants Inducement Awards to New Chief Financial Officer

Pulmonx Corporation Grants Inducement Awards to New Chief Financial Officer
Pulmonx Corporation, a leading global provider of minimally invasive treatments for lung disease, recently announced the granting of inducement awards to Mehul Joshi, who was appointed as the company s Chief Financial Officer in April 2024. The awards, approved by the Compensation Committee of the Board of Directors, include a non-statutory stock option to purchase 241,409 shares of common stock and a time-based restricted stock unit award for 125,870 shares of common stock.
This strategic move by Pulmonx reflects the company s commitment to attracting and retaining top talent in key leadership positions. By offering inducement awards to new executives, Pulmonx aims to incentivize performance and drive shareholder value. The appointment of Mehul Joshi as Chief Financial Officer brings a wealth of experience and expertise to the company, further strengthening its leadership team.

On the trailing twelve months basis In spite of the year on year decrease in LUNG's Current Liabilities to $20.41 millions, cumulative Quick Ratio to 3.21 below the LUNG average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 193 other companies have achieved higher Quick Ratio than Pulmonx. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3761 to 3793.

Explain Quick Ratio?
How much Cash & cash equivalents LUNG�s has?
What are LUNG�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 194
Healthcare Sector	# 872
Within the Market	# 3793

trailing twelve months Quick Ratio Statistics
High	Average	Low
13.21	6.52	3.14
(Sep 30 2021)		(Sep 30 2025)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Safe Pro Group Inc	7.24	$ 10.231 Millions	$ 1.413 Millions
Delcath Systems Inc	7.22	$ 95.902 Millions	$ 13.279 Millions
Streamex Corp	7.16	$ 18.586 Millions	$ 2.595 Millions
Endra Life Sciences Inc	7.04	$ 5.540 Millions	$ 0.787 Millions
Iradimed Corporation	6.45	$ 59.080 Millions	$ 9.164 Millions
Orasure Technologies Inc	6.39	$ 160.582 Millions	$ 25.119 Millions
Alpha Pro Tech Ltd	5.94	$ 18.901 Millions	$ 3.180 Millions
Si bone inc	5.89	$ 141.519 Millions	$ 24.042 Millions
Dexcom Inc	5.84	$ 1,107.000 Millions	$ 189.500 Millions
Cvrx inc	5.78	$ 64.586 Millions	$ 11.177 Millions
Carlsmed Inc	5.67	$ 70.244 Millions	$ 12.397 Millions
Profound Medical Corp	5.24	$ 38.271 Millions	$ 7.304 Millions
Rxsight Inc	5.03	$ 404.247 Millions	$ 80.444 Millions
Transmedics Group Inc	4.81	$ 472.675 Millions	$ 98.283 Millions
Aethlon Medical Inc	4.76	$ 4.934 Millions	$ 1.036 Millions
Bluejay Diagnostics Inc	4.53	$ 9.599 Millions	$ 2.117 Millions
Hyperfine Inc	4.51	$ 43.458 Millions	$ 9.629 Millions
Innovative Eyewear Inc	4.36	$ 2.455 Millions	$ 0.563 Millions
Autonomix Medical Inc	4.23	$ 3.460 Millions	$ 0.818 Millions
Sharps Technology Inc	4.16	$ 12.071 Millions	$ 2.903 Millions
Trisalus Life Sciences Inc	4.14	$ 46.288 Millions	$ 11.172 Millions
Kestra Medical Technologies Ltd	4.12	$ 198.911 Millions	$ 48.269 Millions
Sight Sciences Inc	3.89	$ 79.753 Millions	$ 20.499 Millions
Irhythm Holdings Inc	3.82	$ 839.951 Millions	$ 219.981 Millions
Nutriband Inc	3.77	$ 3.422 Millions	$ 0.907 Millions
Logicmark Inc	3.71	$ 6.596 Millions	$ 1.779 Millions
Axogen inc	3.67	$ 111.412 Millions	$ 30.374 Millions
Procept Biorobotics Corporation	3.60	$ 230.952 Millions	$ 64.196 Millions
Heartbeam Inc	3.54	$ 8.700 Millions	$ 2.460 Millions
Mimedx Group Inc	3.53	$ 135.839 Millions	$ 38.498 Millions

Date modified: 2026-09-26T07:38:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.